These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1281576)

  • 21. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785).
    Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
    Heidt S; Roelen DL; Eijsink C; Eikmans M; van Kooten C; Claas FH; Mulder A
    Clin Exp Immunol; 2010 Feb; 159(2):199-207. PubMed ID: 19922499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
    Blakely ML; Van der Werf WJ; Dalmasso AP; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of immunosuppression by lymphocyte functions in human blood.
    Barten MJ; Rahmel A; Chang H; Tarnok A; Gehlhaar P; Dhein S; Gummert JF
    Transplant Proc; 2002 Nov; 34(7):2876-7. PubMed ID: 12431640
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The unique immunosuppressive activity of brequinar sodium.
    Jaffee BD; Jones EA; Loveless SE; Chen SF
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):19-22. PubMed ID: 7685954
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 28. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation].
    Friedrich J; Erhard J
    Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of mycophenolic acid and tacrolimus on Th17-related immune response.
    Abadja F; Atemkeng S; Alamartine E; Berthoux F; Mariat C
    Transplantation; 2011 Aug; 92(4):396-403. PubMed ID: 21818055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.
    Izeradjene K; Quemeneur L; Michallet MC; Bonnefoy-Berard N; Revillard JP
    Transplant Proc; 2001 May; 33(3):2110-1. PubMed ID: 11377468
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human B cell responses in vitro by RS-61443, cyclosporine A and DAB486 IL-2.
    Grailer A; Nichols J; Hullett D; Sollinger HW; Burlingham WJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):314-5. PubMed ID: 1990540
    [No Abstract]   [Full Text] [Related]  

  • 33. Brequinar sodium: inhibition of dihydroorotic acid dehydrogenase, depletion of pyrimidine pools, and consequent inhibition of immune functions in vitro.
    Simon P; Townsend RM; Harris RR; Jones EA; Jaffee BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):77-80. PubMed ID: 8390742
    [No Abstract]   [Full Text] [Related]  

  • 34. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
    Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
    Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid.
    Vieregge B; Resch K; Kaever V
    Planta Med; 1999 Feb; 65(1):80-2. PubMed ID: 10083851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens no. 408813 III. In vivo activities.
    Fujine K; Ueda H; Hino M; Fujii T
    J Antibiot (Tokyo); 2003 Feb; 56(2):68-71. PubMed ID: 12715863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506).
    Nowaczyk M; Stephień-Sopniewska B; Korczak-Kowalska G; Mrowiec T; Górski A
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):329-32. PubMed ID: 8744655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of FK 506 on B-cell responses.
    Lagodziński Z; Górski A; Stepień-Sopniewska B; Wasik M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):942-3. PubMed ID: 1703359
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined standard and novel immunosuppressive substances affect B-lymphocyte function.
    Matz M; Lehnert M; Lorkowski C; Fabritius K; Weber UA; Mashreghi MF; Neumayer HH; Budde K
    Int Immunopharmacol; 2013 Apr; 15(4):718-25. PubMed ID: 23499640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
    Dayton JS; Turka LA; Thompson CB; Mitchell BS
    Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.